期刊文献+

吡格列酮和二甲双胍在多囊卵巢综合征雌鼠血浆中促炎因子与抑炎因子失衡中的作用 被引量:4

Imbalance of proinflammatory and inflammation inhibit cytokine in plasma of female rats suffering from polycystic ovary syndrome
下载PDF
导出
摘要 目的探讨促炎因子与抑炎因子的失衡在多囊卵巢综合征(PCOS)中的重要作用以及吡格列酮、二甲双胍在维持两者之间平衡的作用。方法将50只雌性SD大鼠随机分为5组,其中40只建立PCOS雌鼠模型后,分别予生理盐水、二甲双胍、吡格列酮以及后面两者联合干预,而10只成年正常雌性SD大鼠,仅予生理盐水灌胃干预。取干预前后雌鼠的血浆行固相夹心法酶联免疫吸附实验(ELISA),检测血清超敏C反应蛋白(hs-CRP)、降钙素原(PCT)、白细胞介素-10(IL-10)与脂联素(ADP)含量变化。结果 PCOS雌鼠hs-CRP、PCT水平较正常雌鼠升高,ADP水平较正常雌鼠下降,差异均有统计学意义(P<0.01);IL-10水平较正常雌鼠下降,差异有统计学意义(P<0.05)。PCOS雌鼠经不同方法干预后,尤其在吡格列酮联合二甲双胍干预雌鼠,hs-CRP、PCT水平较干预前降低,IL-10、ADP水平较干预前升高,差异均有统计学意义(P<0.01)。结论 PCOS雌鼠促炎因子与抑炎因子处于失衡状态,二甲双胍、吡格列酮联合干预可能纠正这种慢性低度炎症状态。 Objective To investigate the role of imbalance of proinflammatory and inflammation inhibitory cytokine in polycystic ovary syndrome(PCOS) and the effects of pioglitazone and metformin on this process. Methods Fifty female rats were randomly divided into 5 groups(n = 10). PCOS models were established in 4 groups,and treat with normal saline,metformin,pioglitazone or metformin plus pioglitazone. Yet the 10 normal matured female rats were fed only with normal saline as controls. ELISA was applied for assessment of serum hs- CRP,PCT,IL- 10 and ADP before and after treatment. Results Significant elevations of serum hs- CRP and PCT with reductions in ADP and IL- 10 were observed in rats with PCOS than controls. Significant improvements in hs- CRP,PCT,IL- 10 and ADP were observed in all treatment groups,especially in combined treatment group,after treatment( P〈0. 01). Conclusion The proinflammatory and inflammation inhibitory cytokines in rats suffering from PCOS were in unbalanced state. Metformin and pioglitazone combined treatment may remedy this state of chronic low- grade inflammation.
出处 《广东医学》 CAS CSCD 北大核心 2014年第14期2145-2147,共3页 Guangdong Medical Journal
基金 广东省人口和计划生育委员会科研项目(编号:20110264)
关键词 多囊卵巢综合征 促炎因子 抑炎因子 吡格列酮 二甲双胍 polycystic ovary syndrome proinflammatory cytokine inhibit inflammatory cytokine metformin pioglitazone
  • 相关文献

参考文献12

  • 1YAVASOGLU I, KUCUK M, COSKUN A, et al. Polycystic ovary syndrome and prolactinoma association[ J]. Inter Med, 2009, 48 (8) : 611 -613.
  • 2BENSON S, JANSSEN O E, HAHN S, et al. Obesity, depression and chronic low - grade inflammation in women with polycystic ovary syndrome[J]. Brain Behav Immun, 2008, 2(2) : 177 -184.
  • 3DIONNE M, PHAM L N, SHIRASU HIZA M, et al. Akt and foxo dysregulation coniribute to infection -induced wasting in Drosophila[J]. Curt" Biol, 2006, 16(20) : 1977 - 1985.
  • 4TEEDE H J, HUTCHISON S, ZOUNGAS S, et al. Insulin resist- ance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS[ J ]. Endocrine, 2006, 30( 1 ) : 45 -53.
  • 5GONZALEZ F. h~ammation in Polycystic Ovary Syndrome: under- pinning of insulin resistance and ovarian dysfunction[J].Steroids, 2012, 77(4) : 300 -305.
  • 6BERTOLI A M, VIL~ L M, REVEILLE J D, et al. Systemic lu- pus erythematosus in a multiethnic US cohort (LUMINA) : LXI. Value of C - reactive protein as a marker of disease activity and damage[J]. JRheumatol, 2008, 35(12): 2355-2358.
  • 7ESCOBAR MORREALE 14 F, LUQUE RAMIREZ M, GONZAL- EZ F. Circulating inflammatory markers in polycystic ovarysyn- drome: a systematic review and meta analysis[J].Fertil Steril, 2011, 95(3) : 1048 - 1058.
  • 8TASDELEN FISGIN N, ALIYAZICIOGLU Y, TANYEL E, et al. The value of neopterin and procalcitonin in patients with sepsis [J]. South MedJ, 2010, 103(3): 216 -219.
  • 9HUR M, MOON H W, YUN Y M, et al. Comparison of diagnostic utility between procalcitonin and C - reactive protein for the pa- tients with blood cuhure - positive sepsis [J]. Korean J Lab Med, 2009, 29(6): 529-535.
  • 10UJI Y, YAMAMOTO H, TSUCHIHASHI H, et al. Adiponectin deficiency is associated with severe polymicrobial sepsis, high in- flammatory cytokine levels, and high mortality[J]. Surgery, 2009, 145(5): 550-557.

同被引文献51

  • 1DIAZ M, CHACON M R, LOPEZ-BERMEJO A, et al. Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue[J]. J Clin Endocrinol Metab, 2012, 97(10): 3630-3638.
  • 2CINAR N, HARMANCI A, BAYRAKTAR M, et al. Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome[J]. Clin Endocrinol, 2013, 78(3): 379-384.
  • 3CHRISTAKOU C, KOLLIAS A, PIPERI C, et al. The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers[J]. Hormones, 2015, 13(4): 488-497.
  • 4GLINTBORG D, MUMM H, ALTINOK M L, et al. Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome[J]. J Endocrinol Invest, 2014, 37(8): 757-764.
  • 5GANIE M A, KHURANA M L, NISAR S, et al. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study[J]. J Clin Endocrinol Metab, 2013, 98(9): 3599-3607.
  • 6KAYA M G, CALAPKORUR B, KARACA Z, et al. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome[J]. Clin Endocrinol, 2012, 77(6): 885-892.
  • 7GODE F, KARAGOZ C, POSACI C, et al. Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate[J]. Arch Gynecol Obstet, 2011, 284(4): 923-929.
  • 8WILLIAMS R M, ONG K K, DUNGER D B. Polycystic ovarian syndrome during puberty and adolescence[J]. Mol Cell Endocrinol, 2013, 373(1/2): 61-67.
  • 9Mayer SB, Evans WS, Nestler JE. Polycystic ovary syndrome and insulin: our understanding in the past, present and future [ J ]. Womens Health (Lond Engl), 2015, 11 (2) : 137 - 149.
  • 10Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome : an Endocrine Society clini- cal practice guideline [ J]. J Clin Endocrin Metab, 2013, 98 (12) : 4565 -4592.

引证文献4

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部